Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions

Director Steve Krognes reports the vesting and acquisition of 154 shares of Guardant Health common stock from restricted stock units on February 28, 2025.

Summary

• Steve Krognes, a director of Guardant Health, Inc., filed a Form 4 on March 4, 2025, reporting changes in beneficial ownership of the company's stock.
• On February 28, 2025, Krognes acquired 154 shares of common stock through the vesting of restricted stock units (RSUs).
• The transaction was executed under transaction code 'M', indicating the exercise or conversion of derivative securities.
• The price per share for the RSU conversion was $0.
• Following the transaction, Krognes directly owns 10,528 shares of common stock and 2,469 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction (RSU vesting) and doesn't necessarily indicate a strong positive or negative outlook.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it is a standard part of executive compensation.

Key Dates